The DCT OS Report: More than 95% of biopharma executives say we're not going back to a site-based-only development model. Learn more
‹

Product Release Notes

Product Release Notes 2.57.0
Product Release Notes 2.56.0
Product Release Notes 2.55.0
Product Release Notes 2.54.0
Product Release Notes 2.53.0
Product Release Notes 2.52.0
Product Release Notes 2.51.0
Product Release Notes 2.50.0
Product Release Notes 2.49.0
Product Release Notes 2.48.0
Product Release Notes 2.47.0
Product Release Notes 2.46.0
Product Release Notes 2.45.0
Product Release Notes 2.44.0
Product Release Notes 2.43.0
Product Release Notes 2.41.0
Product Release Notes 2.40.0
Product Release Notes 2.38.0
Product Release Notes 2.37.0
Product Release Notes 2.36.0
Product Release Notes 2.34.0
Product Release Notes 2.33.0
Product Release Notes 2.32.0
Product Release Notes 2.31.0
Product Release Notes 2.29.0
Product Release Notes 2.28.0
Product Release Notes 2.26.0 & 2.27.0
Product Release Notes 2.25.0
Product Release Notes 2.24.0
Product Release Notes 2.23.0
Product Release Notes 2.22.0
Product Release Notes 2.21.0
Product Release Notes 2.20.0
Product Release Notes 2.19.0
Product Release Notes 2.18.0
Product Release Notes 2.17.0